Oma Säästöpankki Oyj - Balance Sheet
Oma Säästöpankki Oyj
Helsinki OMXH


Assets

Based on the provided financial statements, it appears that the bank's long-term assets, primarily consisting of loans and receivables to customers, have been steadily increasing over the past year, indicating a growing customer base and potentially expanding lending activities. Conversely, the bank's short-term assets, such as cash and central bank deposits, have shown a moderate decrease, suggesting a shift in liquidity management strategies. Overall, the bank's total assets have increased significantly, driven by the growth in long-term assets, while investments in associated companies and other assets have also seen a notable increase, indicating a strategic focus on expanding the bank's investment portfolio.





Shareholders Equity

The Shareholders' Equity of Oma Savings Bank appears to be influenced by the significant increase in the value of equity instruments, particularly those classified as non-quoted, which suggests a strong focus on long-term investments. However, the bank's reliance on Level 3 fair value measurements for these instruments introduces a degree of uncertainty, as the lack of quoted prices and liquid markets can make valuation more subjective. Overall, the bank's equity position appears to be driven by a strategic emphasis on investing in illiquid assets, which may provide long-term benefits but also carries inherent risks.

The value of Oma Savings Bank Equity at the end of Q2 2026 is 623.2 million Euros. The predicted value of Oma Savings Bank Equity at the end of Q2 2027 (e) is 651.3 million Euros.The expected change in one year is 28.1 million Euros, which is a 4.5% increase from the Q2 2026 value. The equity is expected to increase by 21.0 million Euros from 2025 to 2026, representing a 3.4% change. From 2026 to 2027, the equity is predicted to increase by 22.8 million Euros, which is a 3.6% change. The year-end values for Equity are 618.8 million Euros in 2025, 639.8 million Euros in 2026, and 661.0 million Euros in 2027.

*Future dividents are not included in prediction

Olvi Oyj Optomed Oyj










Disclaimer

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.

Before deciding to trade in financial instrument you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.

The data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Contact: quant@quantfactory.eu

About Us